Still, data from P-11 was expected several months ago and the current expectations are now for the data to event in the fourth quarter. It was Gold who said the data would be available in the spring, not IR. Gold knows the trial protocols.
No arguments from me on the incompetence of IR. Last year Monique told me she thought Maged Shenouda was a nice guy just doing his job.
This year she told me Dendreon was trading down in line with other small cap biotechs.
She doesn't have a clue about how investors think or how the market works.
Market Data 
Markets 
AI
